Bio Technology Directory

Categorised Listing of Companies
 
 
 

Bio Technology Dictionary

Terms & Terminologies used in BioTechnology

 
 
  Bio Forum Dedicated
To BioTechnology

Categorised Discussion on BioTechnology Topics
 
  NEWS TOPICS  
 
  NEWS TOPICS TITLE  
   
Bio Technology
Global Bio Technology News
 
 
   
Enzymes
Global News on Enzymes
 
 
   
Genetics
Research & Development in Genetics
 
 
   
Microorganism
Latest News on Microorganisms
 
 
 
Genetics expert to speak in Hastings
 
HASTINGS -- An expert in genetics will give a presentation at 7 p.m. Tuesday at Hastings College, Room 131, in the Morrison-Reeves Science Center.
 Published Date : Mon, 06 Sep 2010 22:39:48 -0700
 
Seattle Genetics achieves milestone under antibody-drug conjugate pact with Agensys
 
Seattle Genetics, Inc. announced that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
 Published Date : Sun, 05 Sep 2010 20:42:31 -0700
 
Genetics may play role in alcohol craving
 
INDIANAPOLIS, Sept. 3 (UPI) -- U.S. researchers have linked craving drink after smelling alcohol to a gene variation. Gene - Genetics - United States - Biology - Eukaryotic
 Published Date : Fri, 03 Sep 2010 20:56:35 -0700
 
Seattle Genetics achieves milestone on Agensys' initiation of AGS-16M8F ADC phase I trial for cancer
 
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
 Published Date : Fri, 03 Sep 2010 00:12:52 -0700
 
Asthma researchers focus on genetics
 
Researchers are calling on Queensland residents to take part in a study to help identify why people develop asthma.
 Published Date : Mon, 06 Sep 2010 19:47:46 -0700
 
Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas
 
BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys’ initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics ...
 Published Date : Thu, 02 Sep 2010 06:18:22 -0700
 
US cattle genetics firm to help Punjab dairying
 
A leading US-based cattle genetics marketing organisation Friday announced it will be working closely with Punjab farmers to promote dairy farming and help the state in achieving success with the 'white revolution'.
 Published Date : Fri, 03 Sep 2010 06:48:10 -0700
 
This Week in PLoS
 
In PLoS Genetics this week, researchers report that their combination of somatic and germline mutation analyses has revealed allelic selection of amplicons in glioblastoma . In examining the tumor and normal-tissue genomes of 178 glioblastoma patients from The Cancer Genome Atlas, the team found that SNP alleles that are most significantly overrepresented in amplicons tend to occur in genes ...
 Published Date : Mon, 06 Sep 2010 07:55:23 -0700
 
Myriad Genetics to Buy Back $100M in Stock
 
Myriad Genetics announced Tuesday another $100 million share buyback program, with expected completion on June 30 of next year.
 Published Date : Tue, 31 Aug 2010 10:38:45 -0700
 
Myriad Genetics to buy back more shares
 
Myriad Genetics to buy back more shares By Lorem Ipsum The Salt Lake Tribune Updated Sep 2, 2010 11:33AM MDT The board of Myriad Genetics Inc. has authorized the repurchase of an additional $100 million of common stock.The new buy-back follows the completion of the Salt Lake City company’s previous stock repurchase that began in May and that also was for $100 million.Myriad expects to complete ...
 Published Date : Wed, 01 Sep 2010 20:06:28 -0700
 
 
 

  Home | About Us | Bio Directory | Bio Dictionary | Bio Forum | Sitemap | Contact Us
 
   
  BioHappenings.com © 2006   |   Privacy Policy